Company Overview
Company Type: Private Company
Company Status: Operating Subsidiary
Website: -
Global Number of Employees (Latest): 2,174
Year Founded: 1945
Total Amount Raised (CAD mm)†: 18.29
Total Rounds of Funding**:1
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Teleflex Medical Incorporated manufactures and markets surgical instruments and devices to customers in the United States and internationally. It offers surgical instruments and devices, cardiac devices, and other specialty products. The company also provides central venous access catheters, respiratory products, anesthesia products, urological catheters, surgical solutions and aids, and left heart products. In addition, it offers dialysis catheters, declotting devices, micro-inducers, arterial lines, and ultrasound products; aerosol delivery products, oxygen therapy products, humidification products, filtration products, ventilation supplies, incentive spirometers, and asthma management products; and catheters, urinary collection devices, and endourological products. Further, the company provides endotracheal tubes, epidural products, oral and nasopharyngeal airways, peripheral nerve blocks, and spinal anesthesia products; ligation, chest drainage, suture, instruments, fiberoptic lighting systems, trocars/ports, and stapling products; FiberOptix IAB catheters, conventional IAB catheters, thermodilution and bipolar pacing catheters/kits, wedge pressure catheters, berman angiographic products, transradial access kits, and flex sheaths; and acute hemodialysis, angioplasty, chronic hemodialysis, diagnostic and drainage, embolectomy, mechanical thrombectomy, and reinforced sheeth products. Furthermore, it offers customer services, refurbishment, and repair services. Teleflex Medical Incorporated was formerly known as Hudson Respiratory Care Inc. and changed the name to Teleflex Medical Incorporated in February 2007. The company was founded in 1945 and is based in Morrisville, North Carolina. It has additional locations in the United States, Latin America, Europe, the Middle East, Africa, Canada, and the Asia Pacific. Teleflex Medical Incorporated operates as a subsidiary of Teleflex Incorporated.

Financial Information (Currency: CAD, in mm) 
Total Revenue
258.4
EBITDA
56.0
EBIT
42.1
Cash & ST Invst.
8.6
Net Income
3.2
Total Debt
292.0
Capital Expenditure
(12.1)
Total Assets
198.8
Total Debt/EBITDA
5.2x
U.S. Number of Employees 2023
-
U.S. Number of Employees 2022
-
U.S. Last Year Employee Growth %
-
Currency in CAD in mm, LTM as of Mar-31-2004 TEV and Market Cap are calculated using the last closing price

Key Professionals
Name
Title
French, Charles A.
Chief Executive Officer
Goldstein, Sam B.
Acting Chief Operating Officer and Acting Chief Operating Officer of River holding Corp
McDowell, Julie
Senior Vice President of Corporate Communications
Magnusson, Ola G.
Senior Vice President and President - Hudson Rci Ab Sweden - Sub

Key Board Members
Name
Title
French, Charles A.
Chief Executive Officer
Gibeck, Sten 
Director and Director of River Holding Corp


Primary Industry Classification
Health Care Supplies


Primary Office Location
3015 Carrington Mill Boulevard | Morrisville, NC | 27560 | United States
Phone: 919-361-3964   Fax: 919-361-4111

Parent Company
Teleflex Incorporated (NYSE:TFX)

Prior Investors
Freeman Spogli Management Co., L.P.


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
Mini-Lap Technologies, Inc.
As of December 2, 2014, Mini-Lap Technologies, Inc. was acquired by Teleflex Medical Incorporated. Mini-Lap Technologies, Inc. develops instrumentation for use in minimally invasive surgery. Its products include Alligator Clamp, a device to grab and retract tissues, such as gallbladder and muscle/fascia/specimen tissues; Babcock Clamp, a device to secure and retract a vascular or infundibular structure; Clutch Clamp, a minimally traumatic device to grasp and retract tissues, such as stomach, esophagus, duodenum, and appendix or ovary; and Bowel Clamp, an atraumatic device to grasp and retract sensitive tissues, which include bowel or bladder. The company’s instruments are used in surgical procedures, including cholecystectomy, appendectomy, and repair of inguinal hernia; and gynecology procedures, such as tubal ligation and other fallopian tube related surgical procedures. It serves patients, clinicians, and surgical administrators. The company was incorporated in 2007 and is based in Dobbs Ferry, New York.

United States and Canada
Health Care Equipment
-
-
-
Tyco Healthcare, Sheridan Endotracheal Tube Line
The Sheridan endotracheal tube line of Tyco Healthcare was acquired by Hudson Respiratory Care Inc. on 9/18/2000.

United States and Canada
Health Care Equipment
-
-
-
Louis Gibeck AB
Louis Gibeck AB is a medical device company that manufactures and distributes anesthesia circuits. The company is based in Upplands Vasby, Sweden and has a manufacturing facility in Malaysia.

Europe
Health Care Equipment
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Dec-11-2014
Dec-2-2014
Merger/Acquisition
Buyer
Mini-Lap Technologies, Inc.
Teleflex Medical Incorporated
NMT Capital
-
May-17-2004
Jul-6-2004
Merger/Acquisition
Target
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
Teleflex Incorporated (NYSE:TFX)
Freeman Spogli Management Co., L.P.
460.00
Aug-6-2001
-
Private Placement
Target
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
Freeman Spogli Management Co., L.P.

11.50
Sep-18-2000
-
Merger/Acquisition
Seller
Tyco Healthcare, Sheridan Endotracheal Tube Line
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
-
Sep-18-2000
-
Merger/Acquisition
Buyer
Tyco Healthcare, Sheridan Endotracheal Tube Line
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
Hudson Respiratory Care Inc. (nka:Teleflex Medical Incorporated)
-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Dec-11-2014
M&A Transaction Closings
Teleflex Medical Incorporated acquired assets of Mini-Lap Technologies, Inc. from NMT Capital and other shareholders.
Feb-12-2014
Product-Related Announcements
Teleflex Medical Announces Worldwide Voluntary Recall of ISIS(TM) HVT(TM) Tracheal Tube Cuffed with Subglottic Secretion Suction Port
Feb-27-2013
Client Announcements
Premier healthcare alliance Healthcare Announces Agreements with B Braun Medical Inc, Becton, Dickinson and Company, Cardinal Health, Inc., Smiths Medical ASD, Inc. and Teleflex Medical Incorporated
Jul-22-2010
Announcements of Earnings
Teleflex Medical Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2010
Feb-24-2010
Product-Related Announcements
Teleflex Medical Incorporated Introduces Teleflex ISIS(TM) HVT(TM) Endotracheal Tube

Competitors
Amphastar Pharmaceuticals, Inc. (NasdaqGS:AMPH), AngioDynamics, Inc. (NasdaqGS:ANGO), Becton, Dickinson and Company (NYSE:BDX), biolitec AG, Boston Scientific Corporation (NYSE:BSX), C. R. Bard, Inc., Cook Medical Incorporated, DMK Pharmaceuticals Corporation (NasdaqCM:DMK), Emergent BioSolutions Inc. (NYSE:EBS), Hikma Pharmaceuticals PLC (LSE:HIK), Inari Medical, Inc. (NasdaqGS:NARI), Johnson & Johnson (NYSE:JNJ), kaleo, Inc., Koninklijke Philips N.V. (ENXTAM:PHIA), Medical Components, Inc., Medtronic plc (NYSE:MDT), Merit Medical Systems, Inc. (NasdaqGS:MMSI), Smiths Medical, Inc., Terumo Medical Corporation, Teva Pharmaceutical Industries Limited (NYSE:TEVA), Total Vein Solutions, LLC, Varian Medical Systems, Inc., Vascular Solutions, Inc.

M&A Advisors
BMC PARTNERS LLP, Citigroup Inc. (NYSE:C)


Advisors
Most Recent Auditor
Deloitte & Touche LLP
M&A Advisors
BMC PARTNERS LLP, Citigroup Inc. (NYSE:C)
Public Offering Advisors
Arthur Andersen LLP, Riordan & McKinzie


Most Recent Auditor
Deloitte & Touche


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
Quant IP GmbH
Quant IP Research Team
Sep 13, 2023 06:00 PM
Teleflex Medical Incorporated
Quant IP Competitive Technology Report Teleflex-Medical-Incorporated 2023-09-01
Reports
31
Quant IP GmbH
Quant IP Research Team
Jul 09, 2023 06:00 PM
Teleflex Medical Incorporated
Quant IP Competitive Technology Report Teleflex-Medical-Incorporated 2023-07-01
Reports
31
Quant IP GmbH
Quant IP Research Team
Jun 16, 2023 06:00 PM
Teleflex Medical Incorporated
Quant IP Competitive Technology Report Teleflex-Medical-Incorporated 2023-06-01
Reports
31
Quant IP GmbH
Quant IP Research Team
May 13, 2023 06:00 PM
Teleflex Medical Incorporated
Quant IP Competitive Technology Report Teleflex-Medical-Incorporated 2023-05-01
Reports
31
GlobalData

Feb 07, 2017 04:12 AM
Teleflex Medical Incorporated
Teleflex to Acquire Pyng Medical
Reports
3


S&P Global Ratings Credit Ratings
Debt Type (Rating Type)
Current Rating
Rating Date
Current CreditWatch / Outlook
Current CreditWatch / Outlook Date
Issuer Credit Rating (Local Currency LT)
NR
Jun-03-2004
NR
6/3/2004 4:28:21 PM
Issuer Credit Rating (Foreign Currency LT)
NR
Jun-03-2004
NR
6/3/2004 4:28:22 PM


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Products
ADAPt Products, Adaptors and Connectors, Aerosol Masks, Aerosol Tubing, Air Cushion Masks, Anesthesia Circuits, Aqua+ and Humid-Vent HMEs, Aquatherm, Arrow Blue FlexTip, Arrow Pressure Injectable Triple Lumen PICC, Breathing Bags, Cannulae, Compressor Accessories, Concha Water, Conchapak, CONCHATHERM 2000 Heater Humidifier, ConchaTherm Heated Humidifiers and Accessories, CONCHATHERM IV Plus Heated Humidifier, Cpap Heated Humidifiers, Cylinder Carts and Bases, Disposable and Re-useable Resuscitation Bags, Endotracheal Tubes, Filters and Ventilarm Monitors, Heated Wire Circuits, Hudson RCI Neb-U-Mask, Humid-Heat System and Accessories, Hyperinflation Bags, Neonatal CPAP, Oral Airways, OSMO Maintenance Free Water Removal, Oxygen Analyzers/Monitors, Oxygen Masks, Oxygen Regulators, Oxygen Sensors, Oxygen Tubing, Peak Flow Meters, Prefilled and Refillable Humidifiers, Prefilled and Refillable Large Volume Nebulizers, SHERIDAN Endotracheal Tubes, Small Volume Nebulizers, Spacers/changers, Teleflex ISIS HVT Endotracheal Tube, Unit Dose Solutions, Voldyne Incentive Breathing Exercisers, Volume Ventilator Circuits


Recent Major Filings

Key Filings
Filed On
Company Name
Source
Form Type
Size
Nov-17-2017
Teleflex Medical Incorporated
SEC
424B5
1 MB
Nov-16-2017
Teleflex Medical Incorporated
SEC
424B5
1 MB
Nov-16-2017
Teleflex Medical Incorporated
SEC
POSASR
594 KB
May-12-2016
Teleflex Medical Incorporated
SEC
424B5
1 MB
May-11-2016
Teleflex Medical Incorporated
SEC
424B2
1 MB
May-11-2016
Teleflex Medical Incorporated
SEC
S-3ASR
900 KB
Mar-30-2015
Teleflex Medical Incorporated
SEC
424B3
1020 KB
Mar-20-2015
Teleflex Medical Incorporated
SEC
S-4
3 MB
Jun-10-2011
Teleflex Medical Incorporated
SEC
424B2
2 MB
Jun-01-2011
Teleflex Medical Incorporated
SEC
424B2
2 MB

Key Board Members Details
Name
Title
Phone
Fax
Email
French, Charles A.
Chief Executive Officer
866-246-6990
919-361-3914
-
Gibeck, Sten 
Director and Director of River Holding Corp
866-246-6990
919-361-3914

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
French, Charles A.
Chief Executive Officer
866-246-6990
919-361-3914
-
Goldstein, Sam B.
Acting Chief Operating Officer and Acting Chief Operating Officer of River holding Corp
866-246-6990
919-361-3914
-
McDowell, Julie
Senior Vice President of Corporate Communications
866-246-6990
919-361-3914
-
Magnusson, Ola G.
Senior Vice President and President - Hudson Rci Ab Sweden - Sub
866-246-6990
919-361-3914

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
